NCT00329940View on ClinicalTrials.gov

Safety and Rheumatologic Tolerability of Letrozole in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer

PHASE3CompletedINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

January 31, 2008

Conditions
Breast Cancer
Interventions
DRUG

Letrozole

Trial Locations (1)

Unknown

Novartis Investigative Site, Saint-Cloud

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY